Always request detailed information from suppliers, including documentation and transparency about product quality and sourcing
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
2023;7:e2300007
The tirzepatide glycine B12 compound guide covers this three-component formulation, and our guide specifically on tirzepatide with glycine explains the stabilizer role in more detail
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment
Check out their BeSafeRx website [archived link] for tips on safely purchasing prescription medications online